PHEX基因剂量与X连锁低磷血症中梅尼埃病及相关听前庭表型的关联
这项前瞻性横断面研究在美国和瑞士的三级学术中心纳入33例成人X连锁低磷血症(XLH)患者,评估PHEX基因剂量与内淋巴囊发育不良型梅尼埃病(MD-hp)的关联。6例(18.2%)符合双侧MD-hp标准,均为半合子男性,支持PHEX基因剂量阈值模型。
要点
- PHEX嵌合或部分缺失男性及女性杂合携带者听前庭表型较轻或缺失。
- 建议对XLH患者进行听前庭监测,尤其半合子男性,以早期风险分层。
核心结论
- 完全PHEX功能缺失的半合子男性导致双侧内淋巴囊发育不良和梅尼埃病,支持内耳特异性PHEX基因剂量阈值模型。
- PHEX嵌合或部分缺失男性及女性杂合携带者保留残余PHEX活性,听前庭表型较轻或缺失。
研究设计与样本
- 前瞻性横断面研究,2021年1月至2024年8月在美国波士顿和瑞士苏黎世三级学术中心招募33例18岁及以上XLH患者。
- 评估包括纯音测听、言语识别测试、冷热试验和视频头脉冲试验、症状史、高分辨率CT评估内淋巴囊发育不良(前庭导水管角度≥140°)、延迟3D FLAIR MRI检测内淋巴积水及PHEX通路基因测序。
主要发现
- 33例患者中6例(18.2%)符合双侧MD-hp标准,均为半合子男性,包括2例有波动性进展性感音神经性听力损失但无眩晕。
- 2例小于40岁的半合子男性显示双侧内淋巴囊发育不良但无临床MD,2例PHEX嵌合或亚效变异男性内淋巴囊解剖正常且无听前庭症状。
- 无女性携带者符合MD-hp标准,5例女性表现为轻度至中度低中频感音神经性听力损失无眩晕,2例女性有孤立传导性听力损失。
关键数值与推荐
- 内淋巴囊发育不良的CT标准为前庭导水管角度≥140°。
临床怎么用
- 对XLH患者,尤其半合子男性,应进行听前庭评估和影像学监测以早期识别MD-hp。
- PHEX基因型和内淋巴囊影像可用于风险分层和个性化随访。
局限性
- 样本量较小(33例),可能限制统计效能和普遍性。
- 横断面设计无法确定因果关系或纵向变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Meniere disease (MD) is a heterogenous disorder whose underlying etiologies remain poorly understood. A subtype of MD characterized by endolymphatic sac (ES) underdevelopment (ES hypoplasia), frequent bilateral disease, and male predominance-termed MD-hp-has emerged as a promising model for genetic investigation. OBJECTIVE: To test whether the PHEX gene underlies the association of XLH with MD-hp. DESIGN, SETTING, AND PARTICIPANTS: This prospective, cross-sectional, study was conducted at tertiary academic centers in the US (Boston, Massachusetts) and Switzerland (Zurich) from January 2021 to August 2024. Participants aged 18 years and older with XLH were recruited. Data were analyzed from October 2024 to August 2025. EXPOSURE: Diagnosis of XLH. MAIN OUTCOMES AND MEASURES: The primary outcome was co-occurrence of XLH and MD-hp as compared with population prevalences. MD-hp assessment included pure-tone audiometry and speech-intelligibility testing, vestibular function testing via caloric and video head-impulse testing, symptom history indicating definite MD criteria, high-resolution computed tomography assessment of ES hypoplasia (angular trajectory of the vestibular aqueduct ≥140°), delayed 3-dimensional fluid-attenuated inversion recovery magnetic resonance imaging for detection of endolymphatic hydrops, and PHEX pathway gene sequencing. RESULTS: Given population prevalences of XLH (approximately 0.005%), MD (approximately 0.2%), and MD-hp (approximately 30% of MD), random co-occurrence would be approximately 1 in 33 million. In this cohort of 33 patients (10 male; mean [SD] age, 53.1 [13.0] years and 23 female; mean [SD] age, 46.2 [17.6] years), 6 (18.2%) met bilateral MD-hp criteria (approximately 1 in 5.5 patients)-a more than 6 million-fold enrichment. All 6 case patients were hemizygous males (including 2 males with fluctuating-progressive sensorineural hearing loss but no vertigo). Two additional hemizygous males younger than 40 years displayed bilateral ES hypoplasia without clinical MD, and 2 males with mosaic or hypomorphic PHEX variants showed normal ES anatomy and no audiovestibular symptoms. No female carriers met MD-hp criteria; instead, 5 females exhibited mild to moderate, low- to mid-frequency sensorineural hearing loss without vertigo, and 2 females had isolated conductive hearing loss. CONCLUSIONS AND RELEVANCE: These findings support an inner ear-specific PHEX gene-dosage threshold model for MD-hp penetrance; complete loss of function in hemizygous males leads to bilateral ES hypoplasia and MD, whereas mosaic or partial-loss variants in males-and heterozygosity in females-permit residual PHEX activity, resulting in milder or absent audiovestibular phenotypes. This genotype-endotype-phenotype linkage (complete PHEX loss, ES hypoplasia, and MD) enables early risk stratification and personalized surveillance and paves the way for targeted therapies in patients with XLH.
引用
- Robles-Bolivar P, Bächinger D, Bose A, et al. Association of PHEX Gene Dosage With Meniere Disease and Related Audiovestibular Phenotypes in X-Linked Hypophosphatemia. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 41989789. doi:10.1001/jamaoto.2026.0021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。